This paper examines two autoimmune disorders — systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD) — as maladaptive immune responses with both genetic and environmental components. The paper describes how lupus causes widespread inflammation across multiple organ systems while IBD specifically targets the gastrointestinal tract through ulcerative colitis and Crohn's disease. It outlines the demographic risk factors, environmental triggers, treatment options, and limitations of current therapies for each condition, highlighting parallels in how the immune system mistakenly attacks the body's own tissues in both diseases.
Autoimmune disorders arise when the body's immune system fails to distinguish between its own healthy tissues and foreign threats, triggering chronic inflammation and tissue damage. Two such disorders — systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD) — share this underlying mechanism while differing considerably in their sites of damage, demographic risk profiles, and available treatments. Both conditions have significant genetic components, yet environmental factors also play an important role in triggering and sustaining disease activity.
Lupus is a chronic, long-term disease that causes inflammation — pain and swelling — and can affect the skin, joints, kidneys, lungs, nervous system, and other organs of the body. Most patients experience fatigue, rashes, arthritis (painful and swollen joints), and fever (Lupus, 2013, American College of Rheumatology). Lupus is caused by a misfiring of the body's immune system. Normally, the body reacts to foreign bodies such as germs or cancerous cells by producing antibodies. In lupus, however, instead of targeting these harmful outside forces, the body attacks its own tissues, leading to widespread inflammation.
As the autoimmune attack progresses, other immune cells join the response. This cascade leads to further inflammation and abnormal blood vessels (vasculitis). The antibodies produced ultimately accumulate in the cells of various organs, where they damage those tissues (Lupus, 2013, American College of Rheumatology). Because the immune assault is systemic rather than localized, lupus can simultaneously compromise multiple organ systems, making it one of the more complex autoimmune conditions to diagnose and manage.
The precise cause of lupus remains undetermined, but the disorder has a clear genetic component. African-Americans and Asians are far more likely to exhibit symptoms than other populations. There may also be a hormonal component, given that women are ten times more likely to be affected than men. However, genetics alone cannot fully explain the disorder. Various environmental triggers appear to precipitate attacks, including viruses, sunlight exposure, and drug allergies. People with lupus may also have an impaired process for clearing old and damaged cells from the body, which causes an abnormal immune response (Lupus, 2013, American College of Rheumatology).
Further complicating the study of lupus is that symptoms tend to wax and wane, and vary considerably in severity from person to person. Some patients' symptoms can be managed with standard NSAIDs (non-steroidal anti-inflammatory drugs), while others may require more intensive treatment with corticosteroids. Lupus cannot be cured; it can only be managed through ongoing pharmaceutical and lifestyle interventions.
Like lupus, inflammatory bowel disease (IBD) can be understood as a misfiring of the body's immune system, although these disorders specifically afflict the digestive tract rather than producing the widespread, multi-organ impact seen in lupus. IBD is a broad term describing conditions characterized by chronic or recurring immune response and inflammation of the gastrointestinal tract. The two most common forms are ulcerative colitis and Crohn's disease (IBD, 2013, CDC). Ulcerative colitis primarily affects the large colon, while Crohn's disease usually targets the small intestine and the beginning portion of the large colon.
Regardless of which form is present, IBD involves the body attacking the cells of the intestine, mistaking beneficial elements such as food particles and normal gut bacteria for dangerous invaders, thereby causing chronic inflammation. This misidentification disrupts normal digestive function and can produce persistent, debilitating symptoms over the course of a patient's lifetime.
"Surgical and drug treatments for Crohn's and colitis"
"Genetic predisposition and environmental triggers in IBD"
You’re 61% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.